$GNCP POSSIBLE JOINT VENTURE IN FUTURE!!
Can you
$GNCP POSSIBLE JOINT VENTURE IN FUTURE!!
Can you Imagine the explosion if/when GNCP announces a JV with a huge reputable mining co???!!! ...there is no doubt in my mind that this aggressive mining company is aggressively seeking a solid JV partner with a ton of cash
excerpt from website:
The Company’s Rationale for Seeking Joint Venture Partners The Company has clearly stated that it is not in the business of “going mining”. with all of the attendant problems associated therewith and the enormous amount of Management and Management attention required, thereby detracting from the Company’s stated core business; which is to add significant value through extensive exploration work and then to either (a) dispose of properties for cash (b) contract the mining of the properties to a third party or (c) to Joint Venture with a Mining Company to produce upon the properties in the Company’s portfolio.
Any such Joint Venture would involve our Partner being solely responsible for Mining operations and only upon an appropriate and equitable profit sharing arrangement.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Legacy of Dr. Charles R. Drew Comes Alive Here's one for the books: a legacy that's still saving lives 85 years after it began. Dr. Charles R. Drew, the mastermind behind blood banking, is getting his due respect with a documentary called Iconic Excellence. No fluff here—this film unveils how the man's breakthroughs during World War II laid down the bedrock of modern...
Continue Reading
Faith and Tech: An Unexpected Alliance? Alright, here's something that'll make you sit up: Catholic college grads are not just busy sipping their morning coffee while they muse over moral philosophy—they're out there on the front lines of artificial intelligence, better prepared and more engaged than their peers from secular schools. According to the latest Holistic...
Continue Reading
Capricor Therapeutics: A Rough Road Ahead If you've got skin in the game with Capricor Therapeutics, these latest developments might have you feeling a bit queasy. Forget the greasy diner fare today; this situation calls for some serious contemplation and maybe a bit of antacid. Over at NASDAQ:CAPR, the air is hot with allegations, stock price nosedives, and looming legal...
Continue Reading
Hisense Extends its UEFA Adventure You ever get the feeling that some partnerships are like a football match made in heaven? Well, Hisense surely seems to think so as they've renewed their gig with UEFA for the 2028 European Championship. That's their fourth tango with UEFA, a relationship that's matured like a fine wine since it all kicked off in 2016. Now, if you're...
Continue Reading
Breaking Down the Exclusive Médunik-Biocodex Partnership Listen, when a company like Médunik Canada, firmly rooted in Blainville, QC, throws its weight behind a rare disease drug like Diacomit®, folks in the industry take notice. Their recent handshake with Biocodex isn't just small talk; it opens doors to change how Dravet syndrome is managed across Canada. This new...
Continue Reading
United Imaging's Big Leap in CT Technology Listen up, folks. United Imaging just got the go-ahead to shake things up in Europe with their dual wide-coverage CT family. We're talking about the uCT SiriuX and the even more amped-up uCT SiriuX Ultrix. They’ve snagged the CE mark, a passport to roll out these impressive machines across the continent. Revolutionizing...
Continue Reading
Starting Your Landscape Redesign the Right Way I’ll give it to you straight: redesigning your yard isn’t just about tossing in some new plants and hoping for the best. Anyone aiming for some backyard nirvana needs to think about the gritty details first—things like drainage, compatibility, and the future growth of those leafy inhabitants. Taking it from Tim Wasmer...
Continue Reading
Passing the Baton in BRP's Financial Helm Alright, folks, grab your coffee and listen up. There's a shakeup coming from the cold corners of Valcourt, Quebec—BRP Inc., the powersports behemoth on the TSX: DOO, has announced a changing of the guard in their finance department. Come October 1st, there's a planned power shift as Sébastien Martel steps down as CFO, passing...
Continue Reading
Investors' Trust on Shaky Grounds There it is, staring right back at investors: a securities fraud class action lawsuit against Aardvark Therapeutics. Not exactly the news a shareholder wants to digest over breakfast. If you’ve got skin in the game with Aardvark Therapeutics (NASDAQ: AARD), you might wanna keep reading. Hagens Berman Sobol Shapiro LLP, a name that's no...
Continue Reading
Jim Morey: Catalyst for Pickleman's Ambitious Dreams You ever heard of a sandwich joint ready to take on the big leagues? Because that's just what Pickleman's Gourmet Café is banking on with their latest move—tapping none other than Jim Morey for their executive advisory board. And let me tell ya, this ain't some run-of-the-mill hire. We're talking about a guy who's...
Continue Reading
Top 5 Most Recently Viewed Articles
AirBoss of America Corp. Announces Earnings Release Date AirBoss of America Corp. (TSX: BOS) (OTCQX: ABSSF) has just shared exciting news regarding its upcoming third-quarter results. The company plans to make their earnings announcement after the markets close on Wednesday. This release will be closely followed by a conference call scheduled for the following day, where...
Continue Reading
Sanofi's Strategic Acquisition of Vicebio In a significant move to strengthen its respiratory vaccines portfolio, Sanofi has made an exciting announcement regarding its acquisition of Vicebio Ltd, a biotechnology company specializing in next-generation vaccines. This acquisition marks a pivotal moment in Sanofi's ongoing commitment to innovation in vaccine development....
Continue Reading
Moodys Corporation's Short Interest Analysis Moodys Corporation (NYSE: MCO) has experienced a notable decrease in short interest, with the short percent of float dropping by 14.17% since the last report. The recent figures indicate that there are approximately 1.61 million shares sold short, which accounts for about 1.03% of all available shares for trading. Based on the...
Continue Reading
Nautilus Biotechnology's Q2 2025 Financial Highlights Nautilus Biotechnology, Inc. (NASDAQ: NAUT) has reported its financial results for the latest quarter, showcasing promising advancements in single-molecule proteome analysis. The company continues to innovate as it heads into the upcoming quarters and seeks to solidify its standing in the life sciences sector. Key...
Continue Reading
Insights on Alliance Witan PLC's Net Asset Value Alliance Witan PLC has shared its recent assessment of net asset value (NAV), a crucial indicator for investors looking to gauge the company’s financial health. The latest figures, derived from the bid price basis, provide investors with a clear picture of the company's market standing. Current NAV Per Ordinary Share As...
Continue Reading